Abstract
The safety, tolerability and efficacy
both in terms of prophylaxis and of the
therapy of bleeding episodes achievable
with Advate® enables us to issue an
overall favorable ethical judgment. It
is nonetheless advisable that decision
makers work towards the creation of
procedures of continuity in treatment
and towards global care for patients,
as well as towards guaranteeing equal
access to medicine for all patients.
| Original language | English |
|---|---|
| Pages (from-to) | 97-102 |
| Number of pages | 6 |
| Journal | Italian Journal of Public Health |
| Volume | 9 |
| Publication status | Published - 2012 |
Keywords
- Advate
- ethical considerations in HTA